
NKE
- Market cap
- $116B
- Sector
- Consumer discretionary

Based on 35 analysts for FY2027
Dollars per share. The record, then the analysts' mean; the dashed lines are their lowest and highest estimate; Oryn's base case is the accent line.
Illustrative estimates; Oryn's line is the base case its DCF run of 8 Sep 2026 stored
Solid, filled: reported, then the consensus meanDashed: the lowest and highest estimateAccent: Oryn's base case, as its DCF run stored it
Oryn's base case against the consensus mean, earnings per share
Each year on one scale, as a difference from that year's consensus mean (the ink line, 0%). The accent mark is Oryn's base case; the grey band is its bear-to-bull range.
Illustrative estimates and paths
Oryn's bear, base and bull are the cases its DCF run of 8 Sep 2026 stored (run run-nke-), year by year. A "Consensus" year is one the run took from the analysts' panel; a "Fade" year is the run's own past it.
Oryn's EPS is each case's net income over the run's 1.48B shares outstanding, counted on 8 Sep 2026; the analysts' EPS is diluted, so at equal earnings Oryn's reads a little higher.
Where this page's consensus covers the year, Oryn's base case is up to +5.7% from its mean: the run read the consensus as of its own date and divides by its own share count.
FY2030–FY2031: the run's fade past the analysts' panel, growth narrowing toward its terminal rate with the margin held.
| Fiscal year | Reported | Consensus low | Consensus mean | Consensus high | Analysts | Oryn bear | Oryn base | Oryn bull | Base vs consensus | Oryn year from |
|---|---|---|---|---|---|---|---|---|---|---|
| FY2022 | $2.58 | — | — | — | — | — | — | — | — | — |
| FY2023 | $3.07 | — | — | — | — | — | — | — | — | — |
| FY2024 | $3.56 | — | — | — | — | — | — | — | — | — |
| FY2025 | $3.52 | — | — | — | — | — | — | — | — | — |
| FY2026 | $3.11 | — | — | — | — | — | — | — | — | — |
| FY2027 | — | $2.60 | $2.78 | $2.99 | 35 | $2.63 | $2.81 | $3.02 | +1.1% | Consensus |
| FY2028 | — | $2.66 | $2.97 | $3.36 | 29 | $2.69 | $3.10 | $3.39 | +4.4% | Consensus |
| FY2029 | — | $2.70 | $3.16 | $3.74 | 23 | $2.73 | $3.34 | $3.78 | +5.7% | Consensus |
| FY2030 | — | — | — | — | — | $2.75 | $3.42 | $3.90 | — | Fade |
| FY2031 | — | — | — | — | — | $2.81 | $3.49 | $3.98 | — | Fade |
Q1 FY2027, from 33 analysts
Moved in ninety days
4 quarters and 3 fiscal years
| Period | Revenue | Earnings per share | Analysts | Revision, 90 days |
|---|---|---|---|---|
| Quarters | ||||
| Q1 FY2027 | $11.50B | $0.66 | 33 | +1.2% |
| Q2 FY2027 | $11.86B | $0.68 | 31 | +0.4% |
| Q3 FY2027 | $12.04B | $0.70 | 29 | +0.0% |
| Q4 FY2027 | $12.77B | $0.74 | 27 | +0.0% |
| Fiscal years | ||||
| FY2027 | $48.17B | $2.78 | 35 | −0.3% |
| FY2028 | $49.23B | $2.97 | 29 | +1.1% |
| FY2029 | $50.22B | $3.16 | 23 | −0.6% |
| Period | Revenue | Estimate | Surprise | Earnings per share | Estimate | Surprise | Analysts |
|---|---|---|---|---|---|---|---|
| Quarters | |||||||
| Q4 FY2026 | $12.62B | $12.49B | +1.0% | $0.71 | $0.67 | +6.0% | 32 |
| Q3 FY2026 | $11.90B | $11.88B | +0.2% | $0.67 | $0.67 | +0.0% | 37 |
| Q2 FY2026 | $11.72B | $11.78B | −0.5% | $0.66 | $0.64 | +3.1% | 37 |
| Q1 FY2026 | $11.36B | $11.52B | −1.4% | $0.64 | $0.65 | −1.5% | 29 |
| Fiscal years | |||||||
| FY2026 | $48.90B | $49.40B | −1.0% | $3.11 | $3.10 | +0.3% | 35 |
| FY2025 | $51.40B | $51.80B | −0.8% | $3.52 | $3.46 | +1.7% | 36 |
Target range vs price
The grey band spans the lowest and highest published target; the marked figure is the mean of 39 targets and the vertical line is today’s price.
Published targets collected to 8 Sep 2026 · third-party; not an Oryn output